MediMabBio
Company Details
Status: Private
Employees: 11-50
Location:
#721, 54, Changeop-ro, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea, 13449
Type:
sample
Technology:
sample
sample
sample
sample
About: MediMabBio is a ground-breaking biotherapeutic company focusing on the generation of novel immunotherapies for the treatment of cancer.
Our discovery platform uses advances in systems biology combined with sophisticated immunological solutions to identify significantly improved first-in-class immuno-oncology drugs that can actively target a range of advanced and solid tumors.
The company has developed a pipeline of highly promising novel drugs that aims to overcome the current limitations of cancer immunotherapy. For this purpose, MediMabBio has established collaborations with core partners of academic, R&D institutions and clinical groups in US, UK, Germany, China and Korea.
Unlock access to company contacts, hot leads, and drug pipelines.
Log in or create a free account now!
MediMabBio | Active clinical trials on ClinicalTrials.gov
Active Clinical Trials Count | 0
No Active Trials Found On ClinicalTrials.gov.